ArticleStem cell research & therapy2025
SUV39H1 facilitate the osteogenic differentiation of dental pulp stem cells by modulating lipid metabolism and mitochondrial dynamics through FASN via non-histone methylation and ubiquitination mechanism.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MicroRNA signatures in inflammatory dental tissues: biomarkers and molecular mechanisms.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTissue engineering technology has limited application in bone tissue regeneration because the mechanism remains unclear. SUV39H1 is a well-characterized histone methyltransferase, but its specific role in bone regeneration of dental pulp stem cells(DPSCs) remains unclear. Mitochondrial energy metabolism plays a regulatory role in osteogenesis, with lipid metabolites serving as critical substrates to fuel this process. FASN has been established as a key regulator of fatty acid metabolism. Therefore, we speculate that SUV39H1 influences the osteogenic differentiation of DPSCs through the mediation of FASN. However, it is still unclear how to regulate the expression of the SUV39H1.
methodsAlkaline phosphatase activity and alizarin red staining were used to detect the osteogenic differentiation of DPSCs. Real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot were performed to detect gene expression levels. Cranioparietal bone replantation in rats and subcutaneous replantation in nude mice were used to confirm bone tissue regeneration. The Seahorse Cell Mitochondria Stress Test was used to detect the oxygen consumption rate. Co-Immunoprecipitation and GST pull-down confirmed the proteins complex. Lipid metabolism sequencing was used to detect the lipid metabolites. Software-based prediction tools analyze gene conservation and interaction networks. Dual-luciferase Reporter Gene Assay was used to detect SUV39H1 regulation by miRNA.
resultsSUV39H1 promoted osteogenic differentiation and bone regeneration in DPSCs. Our results further demonstrated that SUV39H1 enhanced the osteogenic differentiation of DPSCs by promoting lipid metabolism and subsequent mitochondrial energy metabolism. Upon exploring the mechanism by which SUV39H1 regulates lipid metabolism and mitochondrial function. SUV39H1 was found to bind to non-histone and methylated FASN. Simultaneously, FASN was degraded by ubiquitination after SUV39H1 combined with FASN. Thus, SUV39H1 was speculated to methylate FASN, and subsequently recruit a ubiquitination enzyme targeting FASN for degradation. This process modulated lipid and mitochondrial energy metabolism to facilitate the bone regeneration of DPSCs. Regarding the mechanism of regulating SUV39H1 expression, miR-4788 bound to the 3 'UTR of SUV39H1 was found to silence its expression.
conclusionOverall, SUV39H1 facilitated the osteogenic differentiation of DPSCs by modulating lipid metabolism and affected mitochondrial energy metabolism through FASN via non-histone methylation and ubiquitination mechanisms. The expression of SUV39H1was regulated by miR-4788.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.